Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: Systematic review and meta-analysis

Clinical Drug Investigation

Volumn 30, Issue 7, 2010, Pages 419-437

  Jones, Peter ^a   Lamdin, Rain ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Analgesics; Cyclo oxygenase 2 inhibitors; Nonsteroidal anti inflammatories; Soft tissue injuries; Therapeutic use

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; TRAMADOL; VALDECOXIB;

ANALGESIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; GASTROINTESTINAL SYMPTOM; HUMAN; MELENA; META ANALYSIS; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SOFT TISSUE INFECTION; SOFT TISSUE INJURY; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; WEIGHT BEARING;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOFT TISSUE INJURIES;

EID: 77953329962     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11533350-000000000-00000     Document Type: Review

References (145)

1. Willacy H. First aid for soft tissue injuries. Patient Plus 28 July 2009 [online]. Available from URL: http://www. patient.co.uk/showdoc/40001156/ [Accessed 2010 Apr 12]
2. Handoll HHG, Gillespie WJ, Gillespie LD, et al. Moving towards evidence-based healthcare for musculoskeletal injuries: featuring the work of the Cochrane Bone, Joint and Muscle Trauma Group. J Roy Soc Promotion Health 2007 July 1; 127 (4): 168-173
3. Medibank. Safe sports report, 2006 [updated 2006; online]. Available fromURL: http://www.medibank.com.au/Client/ Documents/Pdfs/Medi-Safe-Sports- Report-2006.pdf [Accessed 2008 Feb 28]
4. Cassell EP, Finch CF, Stathakis VZ. Epidemiology of medically treated sport and active recreation injuries in the Latrobe Valley, Victoria, Australia. Br J Sports Med 2003 Oct 1; 37 (5): 405-409
5. Schneider S, Seither B, Tonges S, et al. Sports injuries: population based representative data on incidence, diagnosis, sequelae, and high risk groups. Commentary. Br J Sports Med 2006 April 1; 40 (4): 334-339
6. ACC. Managing soft tissue ankle injuries. Accident Compensation Corporation; 2002 [updated 2002; online]. Available from URL: http://www.acc.co.nz/PRD-EXT- CSMP/groups/external-providers/documents/internet/ wcm z002487.pdf [Accessed 2008 Feb 28]
7. Nicholl JP, Coleman P, Williams BT. The epidemiology of sports and exercise related injury in the United Kingdom. Br J Sports Med 1995 Dec 1; 29 (4): 232-238
8. Kumar V, Abbas AK, Fausto N, editors. Robbins and Cotran Pathologic basis of disease. 7th ed. Philadelphia (PA): Elsevier Saunders, 2005: 49-75
9. Barlow Y, Willoughby J. Pathophysiology of soft tissue repair. Br Med Bull 1992 Jul; 48 (3): 698-711
10. Burke A, Smyth EM, Fitzgerald GA. Analgesic-antipyretic agents. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's The pharmaceutical basis of therapeutics. New York: McGraw-Hill, 2006: 671-716
11. Martin DJ, Shea P. Soft tissue pain and physical therapy. Anaesth Intensive Care Med 2005; 6 (1): 23-25
12. Almekinders LC, Gilbert JA. Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am J Sports Med 1986 July 1; 14 (4): 303-308
13. Bahamonde LA, Saavedra H. Comparison of the analgesic and anti-inflammatory effects of diclofenac potassium versus piroxicam versus placebo in ankle sprain patients. J Int Med Res 1990 Mar-Apr; 18 (2): 104-111
14. Lacey PH, Dodd GD, Shannon DJ. A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders. Eur J Rheumatol Inflamm 1984; 7 (3): 95-104
15. Leadbetter WB. Anti-inflammatory therapy in sports injury: the role of nonsteroidal drugs and corticosteroid injection. Clin Sports Med 1995 Apr; 14 (2): 353-410
16. Lereim P, Gabor I. Piroxicam and naproxen in acute sports injuries. Am J Med 1988 May 20; 84 (5A): 45-49
17. Moran M. An observer-blind comparison of diclofenac potassium, piroxicam and placebo in the treatment of ankle sprains. Curr Med Res Opin 1990; 12 (4): 268-274
18. Moran M. Double-blind comparison of diclofenac potassium, ibuprofen and placebo in the treatment of ankle sprains. J Int Med Res 1991 Mar-Apr; 19 (2): 121-130
19. Reynolds JF, Noakes TD, Schwellnus MP, et al. Nonsteroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. S Afr Med J 1995 Jun; 85 (6): 517-522
20. Van Heerden JJ. Diclophenac sodium, oxyphenbutazone and placebo in sports injuries of the knee. S Afr Med J 1977 Aug 27; 52 (10): 396-399
21. Gotzsche PC. Non-steroidal anti-inflammatory drugs. BMJ 2000 Apr 15; 320 (7241): 1058-1061
22. Jones P. Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence. N Z Med J 1999 Oct 8; 112 (1097): 376-379
23. Motola D, Vaccheri A, Silvani MC, et al. Pattern of NSAID use in the Italian general population: a questionnaire- based survey. Eur J Clin Pharmacol 2004 Dec; 60 (10): 731-738
24. Warner DC, Schnepf G, Barrett MS, et al. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. J Adolesc Health 2002 Mar; 30 (3): 150-153
25. Marnett LJ, Rowlinson SW, Goodwin DC, et al. Arachidonic acid oxygenation by COX-1 and COX-2: mechanisms of catalysis and inhibition. J Biol Chem 1999 Aug 13; 274 (33): 22903-22906
26. Major P. Should non-steroidal anti-inflammatory agents be used in acute soft tissue injuries? Tidsskr Nor Laegeforen 1992 May 10; 112 (12): 1614-1615
27. Paoloni JA, Orchard JW. The use of therapeutic medications for soft-tissue injuries in sports medicine. Med J Aust 2005 Oct 3; 183 (7): 384-388
28. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998; 51 (12): 1357-1365
29. Jones P. NSAIDs in soft tissue injury: current practice vs available evidence. Annual Scientific Meeting of the Australasian College for Emergency Medicine; 1998 Oct 25-30; Gold Coast (QLD)
30. Merry AF, Webster CS, Holland RL, et al. Clinical tolerability of perioperative tenoxicam in 1001 patients: a prospective, controlled, double-blind, multi-centre study. Pain 2004 Oct; 111 (3): 313-322
31. Scheiman JM, Cryer B, Kimmey MB, et al. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury. Clin Gastroenterol Hepatol 2004 Apr; 2 (4): 290-295
32. Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996 Nov 25; 156 (21): 2433-2439
33. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs: differences and similarities. N Engl J Med 1991 Jun 13; 324 (24): 1716-1725
34. Amadio Jr P, Cummings DM, Amadio PB. NSAIDs revisited: selection, monitoring, and safe use. Postgrad Med 1997 Feb; 101 (2): 257-260
35. Browning CH. Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. Int J Psychiatry Med 1996; 26 (1): 25-34
36. Rietveld JA, Pilmore HL, Jones PG, et al. Necrotising fasciitis: a single centre's experience. N Z Med J 1995 Mar 8; 108 (995): 72-74
37. Fu JY, Masferrer JL, Seibert K, et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990 Oct 5; 265 (28): 16737-16740
38. O'Banion MK, Sadowski HB, Winn V, et al. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991 Dec 5; 266 (34): 23261-23267
39. Kujubu DA, Fletcher BS, Varnum BC, et al. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue. J Biol Chem 1991 Jul 15; 266 (20): 12866-12872
40. Munroe DG, Lau CY. Turning down the heat: new routes to inhibition of inflammatory signaling by prostaglandin H2 synthases. Chem Biol 1995 Jun; 2 (6): 343-350
41. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study. A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000 Sep 13; 284 (10): 1247-1255
42. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis: VIGOR study group. N Engl J Med 2000 Nov 23; 343 (21): 1520-1528
43. Bertolini A, Ottani A, Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 2002; 9 (10): 1033-1043
44. Mamdani M, Rochon P, Laupacis A, et al. Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications. CMAJ 2002; 167 (10): 1125-1126
45. Nandave M, Ojha S, Arya D. Should selective cox-2 inhibitors be used more? IJPS 2006; 68: 281-285
46. Spiegel BM, Targownik L, Dulai GS, et al. The costeffectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003 May 20; 138 (10): 795-806
47. Dieppe P. Complicity theory: an explanation for the 'coxib problem'? J R Soc Med 2006 Jun 1; 99 (6): 273-274
48. Okie S. Raising the safety bar: the FDA's coxib meeting. N Engl J Med 2005 Mar 31; 352 (13): 1283-1285
49. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005 Mar 17; 352 (11): 1081-1091
50. Solomon SD, McMurray JJV, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005 Mar 17; 352 (11): 1071-1080
51. Farkouh ME, Kirshner H, Harrington RA, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 2004 Aug 21-27; 364 (9435): 675-684
52. Schnitzer TJ, Burmester GR, Mysler E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004 Aug 21-27; 364 (9435): 665-674 (Pubitemid 39140622)
53. Hinz B, Renner B, Brune K. Drug insight: cyclo-oxygenase- 2 inhibitors - a critical appraisal. Nat Clin Pract Rheumatol 2007 Oct; 3 (10): 552-560
54. Hennekens CH, Borzak S. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease. J Cardiovasc Pharmacol Ther 2008 Mar; 13 (1): 41-50
55. White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: a metaanalysis of randomized clinical trials. Am J Cardiol 2007 Jan 1; 99 (1): 91-98
56. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006 Oct 4; 296 (13): 1633-1644
57. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo- oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006 Jun 3; 332 (7553): 1302-1308
58. Naesh O. Back to the future: postoperative pain management beyond COX-2 inhibitors [online]. N Z Med J 2006; 119 (1242): U2170. Available from URL: http://www.nzma. org.nz/journal/119-1242/ [Accessed 2010 Apr 4]
59. Gierer P, Mittlmeier T, Bordel R, et al. Selective cyclooxygenase- 2 inhibition reverses microcirculatory and inflammatory sequelae of closed soft-tissue trauma in an animal model. J Bone Joint Surg Am 2005 Jan 1; 87 (1): 153-160
60. Anon. Celebrex. Pfizer for Professionals: 2008 [online]. Available from URL: http://www.pfizerpro.com/brands/ Celebrex.jsp [Accessed 2010 Apr 4]
61. Baldwin LA. Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury. Sports Med 2003; 33 (3): 177-185
62. Ivins D. Acute ankle sprain: an update. Am Fam Physician 2006 Nov 15; 74 (10): 1714-1720
63. Mehallo CJ, Drezner JA, Bytomski JR. Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clin J Sport Med 2006 Mar; 16 (2): 170-174
64. Hertel J. The role of nonsteroidal anti-inflammatory drugs in the treatment of acute soft tissue injuries. J Athl Train 1997 Oct; 32 (4): 350-358
65. Almekinders LC, Baynes AJ, Bracey LW. An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts. AmJ Sports Med 1995 Jan-Feb; 23 (1): 119-123
66. Bogatov VB, Weinhold P, Dahners LE. The influence of a cyclooxygenase-1 inhibitor on injured and uninjured ligaments in the rat. Am J Sports Med 2003 Jul-Aug; 31 (4): 574-576
67. Obremsky WT, Seaber AV, Ribbeck BM, et al. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sports Med 1994 Jul 1; 22 (4): 558-561
68. Rahusen FT, Weinhold PS, Almekinders LC. Nonsteroidal anti-inflammatory drugs and acetaminophen in the treatment of an acute muscle injury. Am J Sports Med 2004 Dec; 32 (8): 1856-1859
69. de Gara C, Taylor M, Hedges A. Assessment of analgesic drugs in soft tissue injuries presenting to an accident and emergency department: a comparison of antrafenine, paracetamol and placebo. Postgrad Med J 1982 Aug; 58 (682): 489-492
70. Yates DW, Laing GS, Peters K, et al. Mild analgesics and the accident and emergency department: cost and safety more important than potency? Arch Emerg Med 1984 Dec; 1 (4): 197-203
71. CRD. Treatment modalities for soft tissue injuries of the ankle: a critical review. York: Center for Reviews and Dissemination; 1997 [online]. Available from URL: http:// www.library.nhs.uk/musculoskeletal/ViewResource. aspx? resID=240271 [Accessed 2008 Feb 28]
72. Ogilvie-Harris DJ, Gilbart M. Treatment modalities for soft tissue injuries of the ankle: a critical review. Clin J Sport Med 1995 Jul; 5 (3): 175-186
73. Warden SJ. Cyclo-oxygenase-2 inhibitors: beneficial or detrimental for athletes with acute musculoskeletal injuries? Sports Med 2005; 35 (4): 271-283
74. Hewitt DJ, Todd KH, Xiang J, et al. Tramadol/ acetaminophen or hydrocodone/acetaminophen for the treatment of ankle sprain: a randomized, placebocontrolled trial. Ann Emerg Med 2007 Apr; 49 (4): 468-480
75. Nadarajah A, Abrahan L, Lau FL, et al. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Singapore Med J 2006 Jun; 47 (6): 534-542
76. Ekman EF, Ruoff G, Kuehl K, et al. The COX-2 specific inhibitor valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. Am J Sports Med 2006 Jun; 34 (6): 945-955
77. Diaz JA, Cuervo C, Valderrama AM, et al. Valdecoxib provides effective pain relief following acute ankle sprain. J Int Med Res 2006 Sep-Oct; 34 (5): 456-467
78. Dalton Jr JD, Schweinle JE. Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Ann Emerg Med 2006 Nov; 48 (5): 615-623
79. Petrella R, Ekman EF, Schuller R, et al. Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a doubleblind, randomized controlled trial. Clin J Sport Med 2004 Jul; 14 (4): 225-231
80. Ekman EF, Fiechtner JJ, Levy S, et al. Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. Am J Orthop 2002 Aug; 31 (8): 445-451
81. Graff J, Skarke C, Klinkhardt U, et al. Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers. J Thromb Haemost 2007 Dec; 5 (12): 2376-2385
82. Macintyre PE, Schug SA, Scott DA. Acute pain management: the evidence grows.Med J Aust 2006 Feb 6; 184 (3): 101-102
83. ANZICS. Acute pain management: scientific evidence [online]. Available from URL: http://www.anzca.edu.au/ resources/books-and-publications/acutepain. pdf [Accessed 2008 Feb 28]
84. FDA. COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) [online].Available fromURL: http://www. fda.gov/cder/drug/infopage/cox2/default.htm [Accessed 2008 Feb 28]
85. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclooxygenase- 2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999 Jun 22; 96 (13): 7563-7568
86. McClellan CM, Greenwood R, Benger JR. Effect of an extended scope physiotherapy service on patient satisfaction and the outcome of soft tissue injuries in an adult emergency department. Emerg Med J 2006 May; 23 (5): 384-387
87. Higgins J, Altman D. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 500 (updated February 2008) The Cochrane Collaboration; 2008 [online]. Available from URL: http://www.cochrane-handbook. org [Accessed 2008 Feb 28]
88. Glasziou PP, Sanders SL. Investigating causes of heterogeneity in systematic reviews. Stat Med 2002 Jun 15; 21 (11): 1503-1511
89. Lanier AB. Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury. Sports Med 2003; 33 (3): 177-185
90. Kellett J. Acute soft tissue injuries: a review of the literature. Med Sci Sports Exerc 1986 Oct; 18 (5): 489-500
91. Dreiser RL, Riebenfeld D. A double-blind study of the efficacy of nimesulide in the treatment of ankle sprain in comparison with placebo. Drugs 1993; 46 Suppl. 1: 183-186 (Pubitemid 23324648)
92. Dupont M, Beliveau P, Theriault G. The efficacy of antiinflammatory medication in the treatment of the acutely sprained ankle. Am J Sports Med 1987 Jan 1; 15 (1): 41-45
93. GRADE working group [online]. Available from URL: http://www. gradeworkinggroup.org/ [Accessed 2010 Mar 8]
94. Sterne JAC, Egger M, Moher D, editors. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 500 (updated February 2008). The Cochrane Collaboration; 2008 [online]. Available from URL: http://www.cochrane-handbook. org [Accessed 2008 Feb 28]
95. Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996 Feb 10; 347 (8998): 363-366
96. Gregoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995 Jan; 48 (1): 159-163
97. Hopewell S, Clarke M, Lefebvre C, et al. Handsearching versus electronic searching to identify reports of randomized trials. Cochrane Database Syst Rev 2007; (2): MR000001
98. Deeks J, Altman DG, Bradburn MJ. Chapter 15: Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in healthcare: meta-analysis in context. 2nd ed. London: BMJ, 2001: 285-310
99. Deeks JJ, Higgins JPT, Altman DG, editors. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of interventions version 500 (updated February 2008). The Cochrane Collaboration; 2008 [online]. Available from URL: http://www.cochrane- hand book.org [Accessed 2008 Mar 6]
100. Egger M, Dickersin K, Davey-Smith G. Chapter 3: Problems and limitations in conducting systematic reviews. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in healthcare: meta-analysis in context. 2nd ed. London: BMJ, 2001: 43-65
101. Altman DG. Statistics in medical journals: some recent trends. Stat Med 2000; 19 (23): 3275-3289
102. Egger M, Smith GD. Chapter 2: Principles and procedures for systematic reviews. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in healthcare: metaanalysis in context. 2nd ed. London: BMJ, 2001: 23-42
103. Summary statistics for dichotomous outcome data; 2002 [online]. Available from URL: http://www.cochranenet. org/openlearning/HTML/modA1-5.htm [Accessed 2008 Mar 6]
104. Costa JRB, Rehfeldt LCL, Da Silva SAG. Traumatic sprains and strains: prospective blind study to compare the efficacy of nimesulide and diclofenac. Rev Bras Med 1995; 52 (4): 366-372
105. Ferreira A, Espirandelli L, Peloso UC. Etodolac versus diclofenac in acute sports injuries. Arqu Brasil Med 1992: 175-181
106. Cauchioli CA. Comparative trial between etodolac and naproxen in the treatment of acute sports injuries. Arq Bras Med 1994; 68 (2): 109-114
107. Calligaris A, Scaricabarozzi I, Vecchiet L. A multicentre double-blind investigation comparing nimesulide and naproxen in the treatment of minor sport injuries. Drugs 1993; 46 Suppl. 1: 187-190
108. Marczyk LRS. Randomized study of nimesulide vs. aceclofenac and diclofenac in the treatment of traumatic lesions affecting the locomotor system. Acta Ortop Bras 1997; 5 (3): 103-109
109. Di Marco C, Fesi P, Letizia G. A comparison of the therapeutic effects and tolerability of nimesulide in the treatment of painful inflammatory disorders following injury. Minerva Ortop Traumatol 1989; 40 (2): 111-116
110. Corrales JZ, Torres DL, Cruz MC. Comparative study of nimesulide vs diclofenac in the treatment of musculoskeletal injuries. Invest Med Int 1995; 19:133-141
111. Simon DA, Mesquita M, editors. Double blind evaluation of the efficacy and tolerability of etodolac 200 mg (oral T.I.D.) vs. sodium diclofenac 50 mg oral (T.I.D.) in the treatment of acute sport traumatisms. Congresso ILAR de Reumatologia 17th 1989; Rio de Janeiro
112. ISRCTN217327767 Analgesia in ccute injury (rofecoxib vs. diclofenac lower limb injury). Current Controlled Trials 2010 [online]. Available from URL: http://www.control led-trials.com/ISRCTN21732767/ISRCTN21732767 [Accessed 2008 Aug 22]
113. Mizraji M. Clinical response to etodolac in the management of pain. EurJ Rheumatol Inflam 1990: 35-43
114. Balfour JA. Etodolac: a reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs 1991; 42 (2): 274-299
115. Modesti P, Carletti M, Lana G, et al. Controlled clinical study on the use of nimesulide for sports injuries. Apparato Locomotore 1988; 11 (5): 1
116. D'Hooghe M. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries. Clin Ther 1992 Jul-Aug; 14 (4): 507-516
117. Lovell SJ, Taira T, Rodriguez E, et al. Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial. Acad Emerg Med 2004 Dec; 11 (12): 1278-1282
118. Patel BR. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders. J Indian Med Assoc 2000 May; 98 (5): 250-252
119. Kyle C, Zachariahz J, Kasangra M, et al. Lumiracoxib 400 mg once daily is comparable to naproxen 500mg twice daily for treatment of acute muscular pain following soft tissue injury [abstract]. Ann Rheum Dis 2006 Jul; 65: 241
120. Savini R,Martucci E. Treatment of post-traumatic painful inflammatory disease with nimesulide: controlled study. Il Progresso Medico 1989; 45 Suppl. 1: 27-30
121. Yepes J, Ekman EF, Levy S. Efficacy of celecoxib versus diclofenac in the treatment of acute ankle sprain: a multicenter, doubleblind, randomized, control trial [abstract]. J Clin Rheumatol 2002; 8 Suppl.: 77
122. Anon. A multicenter, randomized, open-label, parallelgroup study to compare the efficacy and tolerability of valdecoxib versus ketorolac in ankle sprain. Protocol No. 872-IFL-0513-1007 PhRMAWebsite (ClinicalStudyResults. org) [online]. Available from URL: http://www.clinical studyresults.org/documents/ company-study [Accessed 2008 Aug 22]-
123. Ekman EF, Ruoff G, Kuehl K, et al. The COX-2 specific inhibitor valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. Am J Sports Med 2006; 34 (6): 945-955
124. Jenoure P, Gorschewsky O, Ryf C, et al. Randomised, double-blind, multicentre study of nimesulide vs diclofenac in adults with acute sport injuries. J Clin Res 1998; 1:343-356
125. Barden J, Edwards JE, Mason L, et al. Outcomes in acute pain trials: systematic review of what was reported. Pain 2004; 109 (3): 351-356
126. Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med 2003 Apr; 10 (4): 390-392
127. Gallagher EJ, Bijur PE, Latimer C, et al. Reliability and validity of a visual analog scale for acute abdominal pain in the ED. Am J Emerg Med 2002 Jul; 20 (4): 287-290
128. Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 2001 Dec; 38 (6): 633-638
129. Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain? Acad Emerg Med 1998Nov; 5 (11): 1086-1090
130. Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J 2001 May; 18 (3): 205-207
131. Powell CV, Kelly AM, Williams A. Determining the minimum clinically significant difference in visual analog pain score for children. Ann Emerg Med 2001 Jan; 37 (1): 28-31
132. Fosnocht DE, Chapman CR, Swanson ER, et al. Correlation of change in visual analog scale with pain relief in the ED. Am J Emerg Med 2005 Jan; 23 (1): 55-59
133. Falgarone G, Zerkak D, Bauer C, et al. How to define a Minimal Clinically Individual State (MCIS) with pain VAS in daily practice for patients suffering from musculoskeletal disorders. Clin Exp Rheumatol 2005 Mar-Apr; 23 (2): 235-238
134. Salo D, Eget D, Lavery RF, et al. Can patients accurately read a visual analog pain scale? Am J Emerg Med 2003 Nov; 21 (7): 515-519
135. Lee JS, Hobden E, Stiell IG, et al. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med 2003 Oct; 10 (10): 1128-1130
136. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003 May; 25 (5): 406-411
137. Jensen MP, Martin SA, Cheung R. The meaning of pain relief in a clinical trial. J Pain 2005 Jun; 6 (6): 400-406
138. Bergh I, Sjostrom B, Oden A, et al. Assessing pain and pain relief in geriatric patients with non-pathological fractures with different rating scales. Aging (Milano) 2001 Oct; 13 (5): 355-361
139. Roelofs PDDM, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database of Systematic Reviews: 2008 issue 1. Chichester: John Wiley & Sons, ltd, 2008: DOI: 10.1002/14651858. CD000396.pub3 ed, 2008
140. Chen LC, Elliott RA, Ashcroft DM. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control. J Clin Pharm Therap 2004; 29 (3): 215-229
141. Cukiernik VA, Lim R, Warren D, et al. Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Ann Pharmacother 2007 Sep; 41 (9): 1368-1374
142. Clark E, Plint AC, Correll R, et al. A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics 2007; 119 (3): 460-467
143. Woo WW, Man SY, Lam PK, et al. Randomized doubleblind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury.Ann EmergMed 2005; 46 (4): 352-361
144. Man SY, Woo WK, Lam PKW, et al. Feasibility study comparing oral paracetamol and oral non-steroidal antiinflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong J Emerg Med 2004 Apr; 11 (2): 78-84
145. Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. BMJ 2004 January 3; 328 (7430): 39-41